Vita Life Sciences Limited provided earnings guidance for the half year ending June 30, 2022. For the period, the company expects sales to be $31.0 million to $32.0 million (H1 2021: $25.7 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 AUD | -0.48% | -9.17% | +16.85% |
1st Jan change | Capi. | |
---|---|---|
+16.85% | 76.97M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- VLS Stock
- News Vita Life Sciences Limited
- Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2022